Trial Profile
COMbination of Clopidogrel and Aspirin for Prevention of REcurrence in Acute Atherothrombotic Stroke Study: Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Embolism and thrombosis; Intracranial-Arteriosclerosis; Stroke
- Focus Therapeutic Use
- Acronyms COMPRESS
- Sponsors Sanofi
- 14 Jul 2016 Results published in the Stroke
- 22 May 2012 Actual patient number (259) added as reported by ClinicalTrials.gov.
- 22 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.